ranked 55th). The “Academic Ranking of World Universities” has been conducted since 2003. It evaluates 1,000 universities in six categories, including academic publication achievements and high-level awards
history. In 2022, researchers used a total of 101.4 million euros for their projects, which employ almost 1,400 people. In 2022, 585 new projects were started. This means that the MHH remains one of the most
patient care at both university medical centres, the state had set up a special fund with a volume of 2.1 billion euros. This is currently the largest construction project in Lower Saxony and probably one of [...] new building and when and in which construction phase. Within the framework of the special funds of 1.05 billion euros available for the MHH, it was also determined how many square metres of floor space
addition, further new biomarkers are to be identified over the next five years. 1,000 affected persons are included in the study About 1,000 patients will be recruited for P4D at the five participating university
stroke unit is a special ward for the treatment of strokes. Last year, about 1,100 patients with apoplexy were treated here. Around 1,800 patients were also treated via the MHH Teleneurology Network. The MHH
monogenetic diseases and those in which genetic effectors play a central role. The prize was awarded on 1 July during the 19th HepNet Symposium. The prize money is provided by Gilead Sciences GmbH, a partner
tumours. The KEYNOTE-966 Phase 3 trial was conducted at 175 medical centres worldwide and included 1,069 patients. Study participants were randomised to receive either treatment with pembrolizumab plus
Pain Outpatient Clinic, Department of Anesthesiology and Intensive Care Medicine, Carl-Neuberg-Str. 1, 30625 Hannover, Germany, phone (0511) 532-3108, e-mail: schmerzambulanz@mh-hannover.de .
the study, one third of whom received a transplant during the observation period. This allowed almost 1,400 data points to be analysed using a complex statistical modelling procedure to decipher the factor
Since 1 July, Clinical Biochemistry has a new director. Christoph Garbers has moved from Otto von Guericke University Magdeburg to the MHH to take over the professorship for biochemistry and the management